C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders

K Turkmen, I Baloglu, H Ozer - International Urology and Nephrology, 2021 - Springer
The complement system plays a significant role within the pathological process of C3
glomerulopathy (C3GP) and atypical hemolytic uremic syndrome (aHUS). In daily practice …

Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome

HT Cook - Current Opinion in Nephrology and Hypertension, 2018 - journals.lww.com
Recent work has provided new insights into the causes of C3 glomerulopathy and aHUS,
and the mechanism by which complement is dysregulated. This is of particular importance …

C3 glomerulopathy and atypical hemolytic uremic syndrome: Two important manifestations of complement system dysfunction

R Bajwa, JA DePalma, T Khan, A Cheema… - Case reports in …, 2018 - karger.com
The advances in our understanding of the alternative pathway have emphasized that
uncontrolled hyperactivity of this pathway causes 2 distinct disorders that adversely impact …

Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated …

GA Ankawi, WF Clark - Case Reports, 2017 - casereports.bmj.com
Historically, patients with kidney diseases caused by genetic or acquired dysregulation of
the complement alternative pathway have been grouped into clinical syndromes, C3 …

Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS …

S Sethi, FC Fervenza - Seminars in thrombosis and hemostasis, 2014 - thieme-connect.com
Dysfunction of the alternative pathway of complement in the fluid phase results in deposition
of complement factors in the renal glomeruli. This results in glomerular injury and an …

[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …

THJ Goodship, HT Cook, F Fakhouri, FC Fervenza… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G)
complement plays a primary role in disease pathogenesis. Herein we report the outcome of …

Kidney diseases associated with alternative complement pathway dysregulation and potential treatment options

P Sanghera, M Ghanta, F Ozay, VK Ariyamuthu… - The American journal of …, 2017 - Elsevier
Atypical hemolytic uremic syndrome and C3 glomerulopathy (dense deposit disease and C3
glomerulonephritis) are characterized as inappropriate activation of the alternative …

C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report

C Huzmeli, F Candan, A Seker, E Yildiz, H Terzi… - Journal of Medical Case …, 2016 - Springer
Background Hemolytic uremic syndrome is characterized by acute renal failure,
thrombocytopenia, and Coombs-negative hemolytic anemia. In C3 mesangial proliferative …

[HTML][HTML] ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL …

THJ Goodship, HT Cook, F Fakhouri… - Nephrology (Saint …, 2018 - journal.nephrolog.ru
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G)
complement plays a primary role in disease pathogenesis. Herein we report the outcome of …

Complement factor I variants in Complement-mediated renal diseases

Y Zhang, RX Goodfellow, N Ghiringhelli Borsa… - Frontiers in …, 2022 - frontiersin.org
C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) are two rare
diseases caused by dysregulated activity of the alternative pathway of complement …